CHEK2 1100delC in patients with metachronous cancers of the breast and the colorectum
-
* Corresponding author: Anna Isinger Anna.Isinger@med.lu.se
BMC Cancer 2006, 6:64 doi:10.1186/1471-2407-6-64
Accesses
- Last 30 days: 15 accesses
- Last year: 218 accesses
- All time: 1371 accesses
Cited by
BioMed Central: 1 citation
|
CHEK2 1100delC is prevalent in Swedish early onset familial breast cancer Sara Margolin, Hans Eiberg, Annika Lindblom, Marie Bisgaard BMC Cancer 2007, 7:163 (17 August 2007) |